Company Search:
Advanced Search
Sponsored Links
Intellia Therapeutics Inc Company Snapshot
Intellia Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Intellia Therapeutics Inc with three other companies in this sector in the United States: Urogen Pharma Ltd (2016 sales of $17.53 million of which 100% was Biopharmaceutical), Anaptysbio Inc ($16.68 million of which 100% was Pharmaceutical), and Egalet Corp ($16.96 million of which 100% was Pharmaceutical Preparations).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Intellia Therapeutics Inc
  Stock Performance Chart for Intellia Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 21.45
(Figures in U.S. Dollars)
1 Week -5.5%   13 Weeks 16.8%  
4 Weeks -24.3%   52 Weeks 56.9%  
Intellia Therapeutics Inc Key Data:
  Ticker: NTLA Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 16,479,000
(Year Ending Jan 2017).
Employees: 104
  Currency: U.S. Dollars Market Cap: 908,091,456
  Fiscal Yr Ends: December Shares Outstanding: 42,335,266
  Share Type: Common Closely Held Shares: 14,192,525
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.